Literature DB >> 26349059

Widespread Expression of Erythropoietin Receptor in Brain and Its Induction by Injury.

Christoph Ott1, Henrik Martens2, Imam Hassouna1,3, Bárbara Oliveira1, Christian Erck2, Maria-Patapia Zafeiriou4, Ulla-Kaisa Peteri1, Dörte Hesse5, Simone Gerhart1, Bekir Altas6, Tekla Kolbow2, Herbert Stadler2, Hiroshi Kawabe6, Wolfram-Hubertus Zimmermann4, Klaus-Armin Nave7,8, Walter Schulz-Schaeffer9, Olaf Jahn5,8, Hannelore Ehrenreich1,8.   

Abstract

Erythropoietin (EPO) exerts potent neuroprotective, neuroregenerative and procognitive functions. However, unequivocal demonstration of erythropoietin receptor (EPOR) expression in brain cells has remained difficult since previously available anti-EPOR antibodies (EPOR-AB) were unspecific. We report here a new, highly specific, polyclonal rabbit EPOR-AB directed against different epitopes in the cytoplasmic tail of human and murine EPOR and its characterization by mass spectrometric analysis of immuno-precipitated endogenous EPOR, Western blotting, immunostaining and flow cytometry. Among others, we applied genetic strategies including overexpression, Lentivirus-mediated conditional knockout of EpoR and tagged proteins, both on cultured cells and tissue sections, as well as intracortical implantation of EPOR-transduced cells to verify specificity. We show examples of EPOR expression in neurons, oligodendroglia, astrocytes and microglia. Employing this new EPOR-AB with double-labeling strategies, we demonstrate membrane expression of EPOR as well as its localization in intracellular compartments such as the Golgi apparatus. Moreover, we show injury-induced expression of EPOR. In mice, a stereotactically applied stab wound to the motor cortex leads to distinct EpoR expression by reactive GFAP-expressing cells in the lesion vicinity. In a patient suffering from epilepsy, neurons and oligodendrocytes of the hippocampus strongly express EPOR. To conclude, this new analytical tool will allow neuroscientists to pinpoint EPOR expression in cells of the nervous system and to better understand its role in healthy conditions, including brain development, as well as under pathological circumstances, such as upregulation upon distress and injury.

Entities:  

Year:  2015        PMID: 26349059      PMCID: PMC4818269          DOI: 10.2119/molmed.2015.00192

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  43 in total

Review 1.  Erythropoietin after a century of research: younger than ever.

Authors:  Wolfgang Jelkmann
Journal:  Eur J Haematol       Date:  2007-01-23       Impact factor: 2.997

2.  Database searching and accounting of multiplexed precursor and product ion spectra from the data independent analysis of simple and complex peptide mixtures.

Authors:  Guo-Zhong Li; Johannes P C Vissers; Jeffrey C Silva; Dan Golick; Marc V Gorenstein; Scott J Geromanos
Journal:  Proteomics       Date:  2009-03       Impact factor: 3.984

3.  Drift time-specific collision energies enable deep-coverage data-independent acquisition proteomics.

Authors:  Ute Distler; Jörg Kuharev; Pedro Navarro; Yishai Levin; Hansjörg Schild; Stefan Tenzer
Journal:  Nat Methods       Date:  2013-12-15       Impact factor: 28.547

4.  Cloning of the human erythropoietin receptor gene.

Authors:  C T Noguchi; K S Bae; K Chin; Y Wada; A N Schechter; W D Hankins
Journal:  Blood       Date:  1991-11-15       Impact factor: 22.113

Review 5.  Erythropoietin: a candidate treatment for mood symptoms and memory dysfunction in depression.

Authors:  Kamilla W Miskowiak; Maj Vinberg; Catherine J Harmer; Hannelore Ehrenreich; Lars V Kessing
Journal:  Psychopharmacology (Berl)       Date:  2011-09-23       Impact factor: 4.530

6.  Covering a broad dynamic range: information processing at the erythropoietin receptor.

Authors:  Verena Becker; Marcel Schilling; Julie Bachmann; Ute Baumann; Andreas Raue; Thomas Maiwald; Jens Timmer; Ursula Klingmüller
Journal:  Science       Date:  2010-05-20       Impact factor: 47.728

7.  Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress.

Authors:  A L Sirén; M Fratelli; M Brines; C Goemans; S Casagrande; P Lewczuk; S Keenan; C Gleiter; C Pasquali; A Capobianco; T Mennini; R Heumann; A Cerami; H Ehrenreich; P Ghezzi
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-20       Impact factor: 11.205

8.  Expression cloning of the murine erythropoietin receptor.

Authors:  A D D'Andrea; H F Lodish; G G Wong
Journal:  Cell       Date:  1989-04-21       Impact factor: 41.582

9.  Erythropoietin: not just about erythropoiesis.

Authors:  Pietro Ghezzi; Myrian Bernaudin; Myriam Bernaudinb; Roberto Bianchi; Roberto Bianchic; Klas Blomgren; Michael Brines; Wendy Campana; Guido Cavaletti; Anthony Cerami; Michael Chopp; Thomas Coleman; Murat Digicaylioglu; Hannelore Ehrenreich; Serhat Erbayraktar; Zebeide Erbayraktar; Max Gassmann; Sermin Genc; Necati Gokmen; Giovanni Grasso; Sandra Juul; Stuart A Lipton; Carla Cerami Hand; Roberto Latini; Giuseppe Lauria; Marcel Leist; Samuel Sathyanesan Newton; Edwige Petit; Lesley Probert; Alessandra Sfacteria; Anna-Leena Siren; Mark Talan; Chris Thiemermann; Daan Westenbrink; Magdi Yaqoob; Changlian Zhu
Journal:  Lancet       Date:  2010-06-19       Impact factor: 79.321

10.  Myelin membrane assembly is driven by a phase transition of myelin basic proteins into a cohesive protein meshwork.

Authors:  Shweta Aggarwal; Nicolas Snaidero; Gesa Pähler; Steffen Frey; Paula Sánchez; Markus Zweckstetter; Andreas Janshoff; Anja Schneider; Marie-Theres Weil; Iwan A T Schaap; Dirk Görlich; Mikael Simons
Journal:  PLoS Biol       Date:  2013-06-04       Impact factor: 8.029

View more
  32 in total

1.  Identification and transcriptome analysis of erythroblastic island macrophages.

Authors:  Wei Li; Yaomei Wang; Huizhi Zhao; Huan Zhang; Yuanlin Xu; Shihui Wang; Xinhua Guo; Yumin Huang; Shijie Zhang; Yongshuai Han; Xianfang Wu; Charles M Rice; Gang Huang; Patrick G Gallagher; Avital Mendelson; Karina Yazdanbakhsh; Jing Liu; Lixiang Chen; Xiuli An
Journal:  Blood       Date:  2019-05-17       Impact factor: 22.113

2.  Neonatal erythropoietin mitigates impaired gait, social interaction and diffusion tensor imaging abnormalities in a rat model of prenatal brain injury.

Authors:  Shenandoah Robinson; Christopher J Corbett; Jesse L Winer; Lindsay A S Chan; Jessie R Maxwell; Christopher V Anstine; Tracylyn R Yellowhair; Nicholas A Andrews; Yirong Yang; Laurel O Sillerud; Lauren L Jantzie
Journal:  Exp Neurol       Date:  2017-12-26       Impact factor: 5.330

3.  Do All X-ray Structures of Protein-Ligand Complexes Represent Functional States? EPOR, a Case Study.

Authors:  Michael S P Corbett; Alan E Mark; David Poger
Journal:  Biophys J       Date:  2017-02-28       Impact factor: 4.033

4.  Partial white and grey matter protection with prolonged infusion of recombinant human erythropoietin after asphyxia in preterm fetal sheep.

Authors:  Guido Wassink; Joanne O Davidson; Simerdeep K Dhillon; Mhoyra Fraser; Robert Galinsky; Laura Bennet; Alistair J Gunn
Journal:  J Cereb Blood Flow Metab       Date:  2016-07-20       Impact factor: 6.200

5.  Erythropoietin protects the subventricular zone and inhibits reactive astrogliosis in kaolin-induced hydrocephalic rats.

Authors:  Wihasto Suryaningtyas; Muhammad Arifin; Fedik Abdul Rantam; Abdul Hafid Bajamal; Yoes Prijatna Dahlan; I Dewa Gede Ugrasena; Sri Maliawan
Journal:  Childs Nerv Syst       Date:  2019-01-19       Impact factor: 1.475

6.  Venlafaxine Mitigates Depressive-Like Behavior in Ovariectomized Rats by Activating the EPO/EPOR/JAK2 Signaling Pathway and Increasing the Serum Estradiol Level.

Authors:  Muhammed A Saad; Ayman E El-Sahar; Rabab H Sayed; Eman M Elbaz; Hebatullah S Helmy; Mahmoud A Senousy
Journal:  Neurotherapeutics       Date:  2019-04       Impact factor: 7.620

Review 7.  Erythropoietin Pathway: A Potential Target for the Treatment of Depression.

Authors:  Chongyang Ma; Fafeng Cheng; Xueqian Wang; Changming Zhai; Wenchao Yue; Yajun Lian; Qingguo Wang
Journal:  Int J Mol Sci       Date:  2016-05-06       Impact factor: 5.923

8.  Erythropoietin signaling in osteoblasts is required for normal bone formation and for bone loss during erythropoietin-stimulated erythropoiesis.

Authors:  Sukanya Suresh; Jeeyoung Lee; Constance T Noguchi
Journal:  FASEB J       Date:  2020-07-15       Impact factor: 5.834

9.  Development of a Neuroprotective Erythropoietin Modified with a Novel Carrier for the Blood-Brain Barrier.

Authors:  Po-Chuan Chiu; Houng-Chi Liou; Thai-Yen Ling; Li-Jiuan Shen
Journal:  Neurotherapeutics       Date:  2020-07       Impact factor: 6.088

10.  Revisiting adult neurogenesis and the role of erythropoietin for neuronal and oligodendroglial differentiation in the hippocampus.

Authors:  I Hassouna; C Ott; L Wüstefeld; N Offen; R A Neher; M Mitkovski; D Winkler; S Sperling; L Fries; S Goebbels; I C Vreja; N Hagemeyer; M Dittrich; M F Rossetti; K Kröhnert; K Hannke; S Boretius; A Zeug; C Höschen; T Dandekar; E Dere; E Neher; S O Rizzoli; K-A Nave; A-L Sirén; H Ehrenreich
Journal:  Mol Psychiatry       Date:  2016-01-26       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.